COVID-19 and Liver Disease

In this video, Dr. Eric Yoshida answers various questions from liver disease patients about COVID-19, including whether they will be more severely impacted than others, if they should continue to see their hepatologist as usual, and when they should go to the hospital.

Meet the Researcher: Dr. Andrew Mason

Meet the Researcher Dr. Andrew Mason

For our most recent Meet the Researcher video, we are pleased to introduce you to Dr. Andrew Mason. Dr. Mason is a Professor of Medicine at the University of Alberta, where he is Director of the Applied Genomics Core and Director of Research for the Division of Gastroenterology.

Meet the Researcher: Dr. Lori West

Meet the Researcher: Dr. Lori West

Today we’re excited to share the first in a new series of videos we’re calling our Meet the Researcher Series. We’re pleased to introduce our first researcher, Dr. Lori West. Dr. West is the Founding Scientific Director of the CDTRP – Canadian Donation and Transplantation Research Program.

Meet the Researcher: Dr. Giada Sebastiani

Meet the Researcher: Dr. Giada Sebastiani

As we marked International NASH Day on June 10, we are pleased to share our latest in our Meet the Researcher series with Dr. Giada Sebastiani, one of the founders and members of the Canadian NASH Network (CanNASH).

Meet the Researcher: Ms. Amber Hager

Meet the Researcher Ms. Amber Hager

In our latest installment of Meet the Researcher, we connected with Ms. Amber Hager to hear how her current research project is improving outcomes and quality of life for children receiving liver transplants.

Prevention and Management of NAFLD/NASH

Prevention and Management of NAFLD:NASH

By adopting a healthy lifestyle, you may prevent obesity – the number one reason for fatty liver disease. It is important to remember that a healthy diet and exercise are important components of any weight-loss regimen. Incorporating these easy everyday tips on nutrition, daily activity, exercise and sleep can help […]

What is Non-Alcoholic Steatohepatitis (NASH)?

What is Non-Alcoholic Steatohepatitis (NASH)?

NASH stands for non-alcoholic steatohepatitis and is the more serious form of NAFLD. NASH affects almost 1.5 million Canadians, even those who drink little or no alcohol. Not only can NASH cause liver scarring, called fibrosis, but about 1 out of 5 adults with NASH can develop potential damage to […]

What is Non-Alcoholic Fatty Liver Disease (NAFLD)?

What is Non-Alcoholic Fatty Liver Disease (NAFLD)?

Non-Alcoholic Fatty Liver Disease (NAFLD) is a liver disease affecting people who drink little to no alcohol. As the name implies, the main characteristics of NAFLD is too much fat stored in liver cells. NAFLD is the most common liver disease in Canada affecting about 20% of Canadians.